CEO August J. Troendle Receives Equity Awards in Medpace Holdings

This Form 4 filing reports that August J. Troendle, CEO, Director, and 10% owner of Medpace Holdings, Inc., received new equity awards on April 24, 2026. Troendle was granted 20,000 employee stock options with an exercise price of $410.54 per share and 10,000 restricted stock units. Both awards vest on the second anniversary of the grant date, contingent on continued employment. The options expire on April 24, 2033. Following these transactions, Troendle directly owns 646,184 shares of common stock and indirectly owns 4,733,019 shares through Medpace Investors, LLC, where he serves as sole manager and controlling unit holder. The filing demonstrates ongoing executive compensation through equity incentives aligned with long-term company performance.